Saint Lazare, Canada

Daniel Dub E

This inventor holds 1 USPTO granted patent. Top assignee: Merck Frosst Canada, Inc.. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Dub E. Retrieved from https://idiyas.com/inventor/daniel-dub-e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Daniel Dub E

Introduction

Daniel Dub E is an accomplished inventor based in St. Lazare, CA. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit leukotriene biosynthesis. His work is vital for advancing therapeutic options in various medical conditions.

Latest Patents

Daniel holds a patent for "Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis." This innovative patent includes compounds having the Formula I, which showcases his expertise in creating effective biochemical solutions. He has 1 patent to his name, reflecting his focused contributions to the field.

Career Highlights

Daniel is currently employed at Merck Frosst Canada, Inc., where he continues to push the boundaries of pharmaceutical research. His role at this prestigious company allows him to collaborate with other talented professionals in the industry.

Collaborations

Throughout his career, Daniel has worked alongside notable colleagues such as Carole Lepine and Daniel Delorme. These collaborations have enriched his research and contributed to the success of his projects.

Conclusion

Daniel Dub E exemplifies the spirit of innovation in the pharmaceutical industry. His work on leukotriene biosynthesis inhibitors is a testament to his dedication and expertise.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…